Our
Science

Pipeline

Walden is advancing a pipeline of novel, disease-modifying therapies that directly target the kidney. We invite you to learn more about our programs, WAL0921 and WAL0623, and how we lever our deep understanding of kidney biology to develop breakthrough therapies that help people with CKD.

Early discovery programs

At Walden we have developed optimized cell-based assays, disease models, and therapeutic discovery tools to interrogate multiple injury pathways to effectively target kidney disease. With this versatile and integrated approach, we are advancing additional programs to further transform the treatment landscape of kidney disease.